Staff Editor
In an interview with PsyPost, Jón Ingi Hlynsson, coauthor of a paper on the pitfalls of psychedelic...
Technology
The edtech industry experienced a funding surge, but investments have leveled off; recent funding rounds showcase AI's...
The diabetes drug Ozempic, along with its counterparts Wegovy, Zepbound, and Mounjaro, are generating significant buzz for...
Ventech has divested its stake in Believe, a digital music company, citing chronic undervaluation due to lack...
The alarming report from the Center for Disease Control reveals that at least three women were diagnosed...
In 2017, Microsoft and OpenAI partnered, but Gates, embroiled in controversy since 2021, quietly influenced Microsoft's AI...
The obsession with immortality drives elites to invest in costly stem cell treatments; for instance, an 84-year-old...
Alphabet, Google's parent company, achieved a $2 trillion market cap milestone, becoming the world's fourth most valuable...
Ketamine has transitioned from a party drug to a respected treatment for severe depression, even catching the...
Dustin Moskovitz, Facebook cofounder and Asana founder, recently accused Tesla of deceiving consumers on a large scale,...
